EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular Generation for CNS Drug Discovery and Design

Shengneng Chen, Ding Luo iD, Weiwei Xue iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00095 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Shengneng Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China. Hauptthemen laut MEDLINE: Drug Discovery, Central Nervous System Agents, Drug Design, Artificial Intelligence. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 7 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, Central Nervous System Drug Key Laboratory of Sichuan Province, Southwest Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Computational drug design is a rapidly evolving field, especially the latest breakthroughs in generative artificial intelligence (GenAI) to create new compounds. However, the potential of GenAI to address the challenges in designing central nervous system (CNS) drugs that can effectively cross the blood-brain barrier (BBB) and engage their targets remains largely unexplored. The integration of GenAI techniques with experimental data sets and advanced evaluation metrics provides a unique opportunity to enhance CNS drug discovery. In this viewpoint, we will introduce the definition of CNS drug-like properties and data resources in CNS drug discovery, highlighting the need to train specialized GenAI models aimed at designing novel CNS drug candidates by efficiently exploring the CNS drug-like space.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryCentral Nervous System AgentsDrug DesignArtificial IntelligenceHumansBlood-Brain BarrierAnimals

Stichwörter der Autor:innen

Blood-Brain BarrierCentral Nervous SystemDrug DesignGenerative AI

Substanzen

Central Nervous System Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China.

ORCID-Profile: Ding Luo, Weiwei Xue

Förderung

  • Natural Science Foundation of Chongqing Municipality
  • Central Nervous System Drug Key Laboratory of Sichuan Province, Southwest Medical University

Zitieren

APA

Chen, S., Luo, D., & Xue, W. (2025). Molecular Generation for CNS Drug Discovery and Design. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00095

Vancouver

Chen S, Luo D, Xue W. Molecular Generation for CNS Drug Discovery and Design. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00095

BibTeX
@article{Chen2025,
  author = {Chen, Shengneng and Luo, Ding and Xue, Weiwei},
  title = {Molecular Generation for CNS Drug Discovery and Design},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00095}
}
Kostenlos starten →